FORMULARY WATCH

Parkinson's & Hep C

Drug therapy options expanded in Parkinson's management

By Heather Leach, PhD
The current global Parkinson's disease market is characterized by a number of unmet needs. Recent approval of novel therapies and reformulations of existing drugs has the potential to fulfill some of these unmet needs, particularly in patients with advanced disease. Current management, new drug approvals

FDA approves Daklinza for hepatitis C genotype 3

By Christine Blank
Daklinza, marketed by Bristol-Myers Squibb in Princeton, N.J., is the first drug that has demonstrated safety and efficacy to treat genotype 3 HCV infections without the need for co-administration of interferon or ribavirin for HCV. Clinical trial details

CONTINUING EDUCATION

MTM essentials for COPD Management: Part 2

This month's CE activity is part of the CPE series, "Medication Therapy Management for the Patient with Respiratory Disease." From April 2015 through December 2015, pharmacists can earn up to 18 hours of CPE credit with 9 monthly knowledge-based activities from the University of Connecticut School of Pharmacy and Drug Topics.

The goal of this month's activity is to assist pharmacists in understanding strategies for improving patient outcomes related to COPD management.

To read and print the article with TEST QUESTIONS, click here.

To proceed to the online exams and earn up to 2 CPE credits, click here to log in with the Session Code: 15DT32-KZV23.

The login to the Online CE Center is
https://web2.uconn.edu/pharmacyce/login.php.
To review you registration page to ensure the data is up to date, or to register, go
https://web2.uconn.edu/pharmacyce/program_register.php.
For a full list of courses, go to
http://pharmacy.uconn.edu/academics/ce/drug-topics-and-uconn-ce/

EDITOR'S PICK

FDA approves Technivie for treatment of hepatitis C virus genotype 4 infections

By Erin Bastick
FDA has approved ombitsavir, paritaprevir and ritonavir (Technivie, AbbVie) for the treatment of hepatitis C virus genotype 4 infections. What's unique about the Technivie approval?

July 31, 2015